Ulys, L.L.C.
- SEC CIK
- 0001340098
- Latest filing
- May 14, 2021
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 14, 2021. Long positions only.
- Positions
- 1
- No 13F data for Q4 2020
- Portfolio value
- $25.4M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 4,321,214 | $25.4M | 100.0% | – | – | History |